Clearance Summary
NASALFLAIR received FDA 510(k) clearance under submission number K951944, sponsored by Airways Ltd., Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Anesthesiology review panel. The statutory decision date of record is 1997-03-28.
- Submission: K951944
- Applicant / Sponsor: Airways Ltd., Inc.
- Clearance pathway: Traditional
- Review panel: Anesthesiology
- Device class: Class II
- Regulation citation: 21 CFR 868.5905
- Decision date: 1997-03-28
Classification & Regulation
This clearance is catalogued under FDA product code BZD and 21 CFR 868.5905, within the Anesthesiology review panel as a Class II device.